Management of mitral regurgitation in short simple steps

Reading Document

Medical Text Search

mitral regurgitation management treatment guidelines

Medical Text Search

mitral valve surgery indications repair replacement

GradeResponse

Mitral Regurgitation (MR) Management

Step 1 — Classify the MR

Type	Cause	Key Feature
Primary (Organic)	Valve leaflet/chordae disease (MVP, rheumatic, endocarditis)	Valve itself is abnormal
Secondary (Functional)	LV dilation/dysfunction pulls leaflets apart	Valve is structurally normal

Step 2 — Assess Severity & Symptoms

Echocardiography is the cornerstone — assess jet severity, LV size/function (EF, LV end-systolic diameter [LVESD])
Severe MR defined as: effective regurgitant orifice area (EROA) ≥ 0.4 cm² (primary) or ≥ 0.2 cm² (secondary)

Step 3 — Medical Management

Primary MR:

No proven therapy delays surgery in asymptomatic severe MR
Treat comorbidities (hypertension, AF, heart failure)

Secondary MR:

Goal-directed medical therapy (GDMT) first: ACE inhibitors/ARBs, beta-blockers, MRAs, SGLT2 inhibitors
CRT (cardiac resynchronization therapy) if LBBB present — can reduce functional MR significantly

Step 4 — Indications for Intervention

(Harrison's, p. 7367; ACC/AHA Guidelines)

Primary MR — operate when:

Symptomatic severe MR (any EF) — especially if repair feasible ✅
Asymptomatic severe MR + EF ≤ 60% or LVESD ≥ 40 mm
Asymptomatic + progressive LV deterioration on serial echo
High likelihood (>95%) of durable repair + low surgical risk

Secondary MR — intervene when:

Persistent severe MR despite optimal GDMT
TEER criteria met (COAPT trial criteria — see below)

Step 5 — Type of Intervention

Option	When Used
Mitral Valve Repair	Preferred for primary MR; lower mortality, preserves LV function
Mitral Valve Replacement	When repair not feasible
TEER (MitraClip/PASCAL)	Primary MR: high/prohibitive surgical risk; Secondary MR: meets COAPT criteria

COAPT trial criteria for TEER in secondary MR:

Severe secondary MR on optimal GDMT
EF 20–50%, LVESD ≤ 70 mm
No severe pulmonary hypertension or severe RV dysfunction

Step 6 — Follow-Up for Asymptomatic Patients

Severity	Echo Interval
Mild MR	Every 3–5 years
Moderate MR	Every 1–2 years
Severe MR (no surgery)	Every 6–12 months

Quick Summary Algorithm

MR diagnosed
    ↓
Primary or Secondary?
    ↓
Severity assessment (Echo)
    ↓
Severe MR?
  ├── YES → Symptomatic? → YES → Surgery (repair preferred)
  │               ↓ NO
  │         EF ≤60% or LVESD ≥40mm? → YES → Surgery
  │               ↓ NO
  │         Watch & serial echo
  └── NO → Medical Rx + surveillance
    ↓
Secondary MR → GDMT first → Persistent? → Consider TEER (COAPT criteria)

(Advanced Training Statement on Interventional Cardiology, p. 25; Harrison's, p. 7367)

This is a shared conversation. Sign in to Orris to start your own chat.